ACAD
30.94
-0.14
-0.45%
AEMD
1.51
-0.02
-1.31%
APRI
1.48
-0.01
-0.67%
ARNA
20.26
-0.27
-1.32%
ATEC
1.94
0.00
N/A%
CNAT
5.15
+0.14
+2.79%
CRXM
0.17
+0.01
+4.20%
CYTX
0.311
-0.011
-3.5039%
DXCM
73.06
-0.14
-0.19%
GNMK
9.54
-0.06
-0.63%
HALO
11.9
+0.02
+0.17%
ILMN
190.68
+1.36
+0.72%
INNV
0.108
+0.008
+7.5000%
INO
5.46
+0.01
+0.18%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
N/A%
LGND
126.55
+0.29
+0.23%
LPTN
2.93
-2.93
-100.00%
MBVX
0.51
+0.01
+2.00%
MEIP
2.6
-0.08
-2.99%
MNOV
4.97
0.00
0.00%
MRTX
5.45
-0.15
-2.68%
MSTX
0.13
-0.01
-5.28%
NBIX
52.13
-0.02
-0.04%
NUVA
64.48
0.00
N/A%
ONCS
0.89
-0.03
-3.2500%
ONVO
1.81
-0.04
-2.16%
OREX
2.39
-0.03
-1.24%
OTIC
20.25
+1.5
+8.00%
QDEL
32.77
+0.16
+0.49%
RCPT
231.96
0.00
0.00%
RGLS
0.846
+0.02
+2.4573%
RMD
73.44
+0.37
+0.51%
SCIE
0
0.00
-33.3333%
SPHS
1.82
-0.08
-4.21%
SRNE
1.7
-0.05
-2.86%
TROV
0.82
-0.01
-1.17%
VICL
2.34
-0.09
-3.70%
VOLC
18
0.00
0.00%
ZGNX
12.3
+0.05
+0.41%
ACAD
30.94
-0.14
-0.45%
AEMD
1.51
-0.02
-1.31%
APRI
1.48
-0.01
-0.67%
ARNA
20.26
-0.27
-1.32%
ATEC
1.94
0.00
N/A%
CNAT
5.15
+0.14
+2.79%
CRXM
0.17
+0.01
+4.20%
CYTX
0.311
-0.011
-3.5039%
DXCM
73.06
-0.14
-0.19%
GNMK
9.54
-0.06
-0.63%
HALO
11.9
+0.02
+0.17%
ILMN
190.68
+1.36
+0.72%
INNV
0.108
+0.008
+7.5000%
INO
5.46
+0.01
+0.18%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
N/A%
LGND
126.55
+0.29
+0.23%
LPTN
2.93
-2.93
-100.00%
MBVX
0.51
+0.01
+2.00%
MEIP
2.6
-0.08
-2.99%
MNOV
4.97
0.00
0.00%
MRTX
5.45
-0.15
-2.68%
MSTX
0.13
-0.01
-5.28%
NBIX
52.13
-0.02
-0.04%
NUVA
64.48
0.00
N/A%
ONCS
0.89
-0.03
-3.2500%
ONVO
1.81
-0.04
-2.16%
OREX
2.39
-0.03
-1.24%
OTIC
20.25
+1.5
+8.00%
QDEL
32.77
+0.16
+0.49%
RCPT
231.96
0.00
0.00%
RGLS
0.846
+0.02
+2.4573%
RMD
73.44
+0.37
+0.51%
SCIE
0
0.00
-33.3333%
SPHS
1.82
-0.08
-4.21%
SRNE
1.7
-0.05
-2.86%
TROV
0.82
-0.01
-1.17%
VICL
2.34
-0.09
-3.70%
VOLC
18
0.00
0.00%
ZGNX
12.3
+0.05
+0.41%
Home » Archive by Category

Xconomy

Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal

June 12, 2017 – 3:55 am

Dragonfly Therapeutics, a stealthy startup formed by well-known cancer researchers on both coasts and backed by a high-powered group of family offices, has inked its first partnership. Celgene, of…

[[Click headline to continue reading.]]

Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More

June 9, 2017 – 2:30 am

The New York Times Magazine wrote a few weeks ago about the extraordinary metabolic changes in a python after it gulps down a 50,000 calorie meal. The biomedical world was like a postprandial python…

[[Click headline to continue reading.]]

ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity

June 6, 2017 – 9:10 am

[Note: Ben Fidler coauthored this report.] The American Society of Clinical Oncology conference is wrapping up, and the closely watched medical meeting-slash-hype machine produced its usual array of…

[[Click headline to continue reading.]]

Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests?

June 3, 2017 – 3:25 am

When the FDA last week approved Merck’s cancer drug pembrolizuamb (Keytruda) for tumors with a specific genetic signature, regardless of what body part they originated in, it was a watershed moment…

[[Click headline to continue reading.]]

Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More

June 2, 2017 – 2:00 am

Over the next four days, the Second City will be the center of the biomedical world. The American Society of Clinical Oncology’s annual meeting in Chicago brings together thousands of researchers…

[[Click headline to continue reading.]]

With Gene Therapy for Diabetes, San Antonio Researcher Eyes Funding

May 31, 2017 – 7:19 am

San Antonio — Most diabetes treatments work by giving the body the insulin it needs to break down sugar. But that approach deals with the symptoms of diabetes. In recent years, scientists and…

[[Click headline to continue reading.]]

As Big Cancer Trials Ramp Up, Grail Goes Global, Merges With Cirina

May 31, 2017 – 4:45 am

Grail, the Illumina (NASDAQ: ILMN) spinout aiming to develop a blood test that can detect cancer at its earliest stages, has gone global. The Menlo Park, CA, startup, is merging with China’s Cirina,…

[[Click headline to continue reading.]]

In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions

May 31, 2017 – 2:35 am

Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the…

[[Click headline to continue reading.]]

RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug

May 30, 2017 – 12:05 pm

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be…

[[Click headline to continue reading.]]

Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine

May 30, 2017 – 7:57 am

The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nation’s top drug evaluator, Janet Woodcock, believes they aren’t necessary for all new…

[[Click headline to continue reading.]]